Don’t know if anyone heard KARxt has passed phase 3 clinical trials. Karuna plans to submit application to FDA later this year. It definently will be accepted the question is it’s efficacy. One third dropped out of the trials for reasons not related to Side effects. I still haven’t heard of anyones expierence with the drug and how and what it makes people feel. I believe the M4 PAM drug Emriclide will be more effacious
2 Likes
That’s great news. I’m hopeful about these new medications, they may potentially improve some of our lives.
What I’m really waiting for is when these new meds are out on the market, so that I can read anecdotes about them before deciding to maybe try.
3 Likes
There are other KarXT phase 3 trials still running. https://clinicaltrials.gov/ct2/results?cond=&term=Karxt&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&phase=2&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=
Company predicts launch second half of 2024.
2 Likes